Concepedia

Laura Boldrini

LB

4

Publications

75

Citations

4

H-Index

2013

Active since

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

University of Milan

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Istituto Oncologico Veneto

Laura Boldrini is an author at Fondazione IRCCS Istituto Nazionale dei Tumori.

Publications per year

2013–2025

4

Publications

4

Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study

L. Provenzano, M.V. Dieci, G. Curigliano et al. · Annals of Oncology · 2025 · 26 citations · Full text

Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors

Emma Zattarin, Daniele Presti, Luigi Mariani et al. · npj Breast Cancer · 2023 · 22 citations · Full text

Dietary habits and growth: an urban/rural comparison in the Andean region of Apurimac, Peru.

Laura Andrissi, Giovanni Mottini, Valeria Sebastiani et al. · PubMed · 2013 · 14 citations · Full text

Biomarkers for Antibody–Drug Conjugates in Solid Tumors

Jalissa Katrini, Laura Boldrini, Celeste Santoro et al. · Molecular Cancer Therapeutics · 2024 · 13 citations

Rows per page

1–4 of 4